Physician profile
Atish Mathur
NPI 1588895064
$290,777.80
in general payments reported to CMS, 2019-2025
23 companies · $84K in 2025
The $84K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,545 · 2020: $2,069 · 2021: $7,102 · 2022: $34K · 2023: $101K · 2024: $58K · 2025: $84K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $131K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Travel and Lodging: $45K · Food and Beverage: $7,659 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,002.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $59,115.63 |
| Travel and Lodging | $45,277.00 |
| Food and Beverage | $7,659.26 |
| Education | $123.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $216,499.05 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic, INC. | $64,209.36 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $3,168.43 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Medtronic Vascular, INC. | $2,918.26 | 2019-2020 | |
| Abbott Laboratories | $1,698.13 | 2019-2025 | Portico, Amplatzer Amulet, Mitraclip |
| Abiomed | $701.51 | 2019-2025 | Impella |
| Astrazeneca Pharmaceuticals Lp | $326.23 | 2019-2024 | Brilinta, Farxiga |
| Biotronik INC. | $311.08 | 2022-2023 | Orsiro Mission, Nhancer Rx, Trapit |
| Shockwave Medical, INC | $193.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiac Dimensions, INC. | $162.55 | 2022 | |
| Jenavalve Technology, INC. | $112.15 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $98.54 | 2019-2025 | Camzyos, Eliquis |
| Inari Medical, INC. | $89.21 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $64.17 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $54.99 | 2024 | Uptravi, Opsumit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $54.76 | 2019-2022 | |
| Philips North America LLC | $27.79 | 2024 | (Ao0) Igt Devices Intracardiac |
| Cardiovascular Systems INC. | $21.30 | 2022 | |
| Pfizer INC. | $15.45 | 2024 | |
| Chiesi USA, INC. | $14.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.78 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.77 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Atish Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.